Healthequity Inc (NASDAQ:HQY) price on Friday, February 28, rose 2.58% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $109.76.
A look at the stock’s price movement, the close in the last trading session was $107.00. The PE ratio in trailing twelve months stood at 100.13. Turning to its 52-week performance, $115.59 and $65.01 were the 52-week high and 52-week low respectively. Overall, HQY moved 0.88% over the past month.
Healthequity Inc’s market cap currently stands at around $9.51 billion, with investors looking forward to this quarter’s earnings report slated for in April.
Analysts have a consensus estimate of 305.82M for the company’s revenue for the quarter, with a low and high estimate of 300.12M and 312.04M respectively. The average forecast suggests up to a 16.55% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.19B, representing a 19.43% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HQY is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 10 recommend HQY as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 3.83, with HQY’s current price about -1.15% and 5.22% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.18, while 7-day volatility ratio is 3.99% and 2.89% in the 30-day chart. Further, Healthequity Inc (HQY) has a beta value of 0.62, and an average true range (ATR) of 3.42. Analysts have given the company’s stock an average 52-week price target of $107.5, forecast between a low of $103 and high of $112. Looking at the price targets, the low is 6.16% off current price level while to achieve the yearly target high, price needs to move -2.04%. Nonetheless, investors will most likely welcome a 2.06% jump to $107.5 which is the analysts’ median price.
If we refocus on Healthequity Inc (NASDAQ:HQY), historical trading data shows that trading volumes averaged 760.09K over the past 3 months. The company’s latest data on shares outstanding shows there are 86.82 million shares.
The 2.45% of Healthequity Inc’s shares are in the hands of company insiders while institutional holders own 104.92% of the company’s shares. Current price change has pushed the stock 14.39% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HQY stock continues to rise going into the next quarter.
